Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Rising Pool of Geriatrics Drives Global Dental Bone Graft Substitutes and Other Biomaterials Market

Blog Description

Bone grafting is an integral part of periodontal procedures, as it increases the length of the bone supporting dental implants. The high prevalence of periodontal diseases, along with the rise in the number of dental fractures over the years, has augmented the global dental bone graft substitutes and other biomaterials market. In the coming years, the demand for dental bone graft substitutes and other biomaterials is expected to rise due to the increasing geriatric population, which is prone to periodontal diseases. Furthermore, poor oral hygiene will also boost the market in the near future. The only restraint on the global dental bone graft substitutes and other biomaterials market is the implementation of the Affordable Care Act in the United States.

The global dental bone graft substitutes and other biomaterials market is segmented on the basis of materials and geography.  On the basis of materials, the market is segmented into natural, ceramics, composites, and polymers. The natural segment is further sub-segmented into allografts and xenografts. Allografts are inclusive of freeze dried bone allografts, fresh frozen bone, and demineralized freeze dried bone allografts, while xenografts only include freeze dried bone xenografts and demineralized freeze dried bone xenografts. Ceramics are inclusive of hydroxyapatite, tricalcium phosphate, biphasic calcium phosphates, and others. The composites segment further includes collagen/ceramic composite and bioactive glass, while the polymers segment covers polymethylmethacrylate and polyhydroxyethylmethacrylate. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Browse the full Report of Global Dental Bone Graft Substitutes and Other Biomaterials Markethttp://www.mrrse.com/dental-bone-graft-substitutes-biomaterials

Preference for Natural Bone Graft Substitutes Boosts Segment’s Growth

Of the types of materials, the natural segment dominated the overall dental bone graft substitutes and other biomaterials market in 2013. The allografts sub-segment held the biggest chunk of the market due to its wide acceptance amongst the patients and compatibility with tissues after transplantation. Furthermore, the allografts market is also being driven by growth in the manufacturing of allografts. Xenografts, a key sub-segment of the natural segment, are expected to grow at a CAGR of 11.1% between 2014 and 2020. This growth will be attributable to the rise in tissue banks for collecting bone tissues that are extracted from bovine animals. This trend is also being supported by the growing adoption of grafts derived from animals.

Rise of Dental Tourism to Push Dental Bone Graft Substitutes and Other Biomaterials Market in Asia Pacific

In terms of geography, North America and Europe together held a share of more than 70% in the total dental bone graft substitutes and other biomaterials market. The strong presence of some of the important players in these regions is the primary reason for this dominance. However, analysts predict that Asia Pacific will register a robust CAGR in the coming few years due to a rising pool of geriatrics and increasing dental tourism. Furthermore, the ceramics segment will grow at an accelerated pace in Asia Pacific as patients show reluctance towards xenografts.

Browse the full Press Release of Global Dental Bone Graft Substitutes and Other Biomaterials Markethttp://www.mrrse.com/dental-bone-graft-substitutes-biomaterials-market

Global Dental Bone Graft Substitutes and Other Biomaterials Market to Register a CAGR of 10.6% from 2014 to 2020

Owing to the aforementioned reasons, the global market for dental bone graft substitutes and other biomaterials is expected to register a CAGR of 10.6% from 2014 to 2020. Some of the top players contributing to this positive trend will be ACE Surgical Supply Company, Inc., Biomet, Inc., BioHorizons IPH, Inc., DENTSPLY International Inc., Institut Straumann AG, DePuy Synthes Companies, Geistlich Pharma AG, Zimmer Holdings, Inc., and Medtronic, Inc.